
Congress trades
Starling Oncology, Inc. (STLN)
NASDAQ · Healthcare · 5 congress trades · last filed 3 days ago
About Starling Oncology, Inc.
from the company's filings and listing, as of Oct 27, 2026- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Chief executive
- Daniel Virnich
- Employees
- 641
- Listed since
- Aug 4, 2026
- Market value
- $628.9M
- Price to earnings (12 mo)
- -
- Net income per share, as reported (12 mo)
- -$0.35
- Dividend yield
- -
Earnings
5 reported quarters| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 6, 2026 | -$0.08 | -$0.06 | $161.3M | $155.7M | EPS miss, GAAPRevenue beat |
| Q1 FY2026reported May 7, 2026 | -$0.02 | -$0.09 | $147.4M | $142.1M | EPS beat, GAAPRevenue beat |
| Aug 13, 2025 | -$0.15 | -$0.12 | $119.8M | $113.3M | EPS miss, GAAPRevenue beat |
| May 14, 2025 | -$0.21 | n/a | $104.4M | n/a | EPS n/aRevenue n/a |
| Aug 13, 2024 | -$0.17 | -$0.09 | $98.6M | $103.3M | EPS miss, GAAPRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Congress trades in STLN
5 disclosures of 5 on record · median 34d of the 45 allowedSince the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Richard BlumenthalSpouse | Stock | Sale (Partial) | $15,001 - $50,000 | -9.6% since the saleEstimated exit price $6.96, close on Fri Sep 18Current price $6.29, close on Mon Oct 26 | Sep 18, 2026 | Oct 26, 2026 | 38d |
| Richard BlumenthalSpouse | Stock | Sale (Partial) | $1,001 - $15,000 | -9.6% since the saleEstimated exit price $6.96, close on Fri Sep 18Current price $6.29, close on Mon Oct 26 | Sep 18, 2026 | Oct 26, 2026 | 38d |
| Richard BlumenthalSpouse | Stock | Sale (Partial) | $1,001 - $15,000 | -10.8% since the saleEstimated exit price $7.05, close on Tue Sep 22Current price $6.29, close on Mon Oct 26 | Sep 22, 2026 | Oct 26, 2026 | 34d |
| Richard BlumenthalSpouse | Stock | Sale (Partial) | $15,001 - $50,000 | -10.8% since the saleEstimated exit price $7.05, close on Tue Sep 22Current price $6.29, close on Mon Oct 26 | Sep 22, 2026 | Oct 26, 2026 | 34d |
| Richard BlumenthalSpouse | Stock | Sale (Partial) | $1,001 - $15,000 | -7.8% since the saleEstimated exit price $6.82, close on Wed Sep 23Current price $6.29, close on Mon Oct 26 | Sep 23, 2026 | Oct 26, 2026 | 33d |
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
Every Congress trade in STLN, filterable by party, chamber, type and account.
Questions
Which members of Congress have traded STLN?
Richard Blumenthal disclosed STLN transactions in the filings shown here.
How quickly are STLN trades disclosed?
Congressional disclosures took a median of 34 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 28, 2026.
